Drug-drug interaction between apalutamide and atorvastatin through breast cancer resistance protein in an outpatient.

IF 0.9 4区医学 Q4 PHARMACOLOGY & PHARMACY

International journal of clinical pharmacology and therapeutics Pub Date : 2022-05-23 DOI:10.5414/CP204198

Ayako Watanabe, K. Momo, Katsumi Tanaka, Masaki Kida, Remi Kuchira, Hiromi Koshizuka, Kota Nishimura, M. Morita, Masahiro Yamamoto, Tadanori Sasaki

引用次数: 0

查看原文本刊更多论文

门诊患者阿扑他胺和阿托伐他汀通过乳腺癌症耐药性蛋白的药物相互作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International journal of clinical pharmacology and therapeutics 医学-药学

CiteScore

1.70

自引率

12.50%

发文量

116

审稿时长

4-8 weeks

期刊介绍： The International Journal of Clinical Pharmacology and Therapeutics appears monthly and publishes manuscripts containing original material with emphasis on the following topics: Clinical trials, Pharmacoepidemiology - Pharmacovigilance, Pharmacodynamics, Drug disposition and Pharmacokinetics, Quality assurance, Pharmacogenetics, Biotechnological drugs such as cytokines and recombinant antibiotics. Case reports on adverse reactions are also of interest.